We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Astrazeneca Plc | LSE:AZN | London | Ordinary Share | GB0009895292 | ORD SHS $0.25 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-106.00 | -0.87% | 12,050.00 | 12,036.00 | 12,038.00 | 12,178.00 | 12,010.00 | 12,092.00 | 1,635,146 | 16:35:23 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 45.81B | 5.96B | 3.8415 | 31.34 | 186.61B |
Date | Subject | Author | Discuss |
---|---|---|---|
25/5/2021 14:53 | So what's Biden said now ? :-S | philanderer | |
25/5/2021 14:48 | AstraZeneca: Deutsche Bank reiterates buy with a target price of 10,200p | philanderer | |
25/5/2021 14:10 | I'd have thought AZN would have had a nod and a wink before going for this deal. | philanderer | |
23/5/2021 00:16 | Covid: Pfizer and AstraZeneca jabs effective against Indian variant - study | philanderer | |
22/5/2021 15:47 | EU's actions may have damaged the Oxford vaccine take up in EU yet other countries are willing to put their faith in the vaccine. The court will judge the facts but the court of the people could have already decided EU have a case to answer re damaging the vaccine safety protocol to hide poor leadership, etc? | stutes | |
21/5/2021 16:31 | don't know about monty's but Farallon Capital Management, L.L.C.'s shorts are well on fire, increased to 0.60% of shares in issue 4 weeks ago. Ha! | nerdlinger | |
21/5/2021 10:58 | Two doses of the AstraZeneca Covid-19 vaccine provide between 85% and 90% protection from symptomatic disease, according to a study from Public Health England. Bloomberg | philanderer | |
21/5/2021 07:35 | Japan's approval of the COVID 19 vaccine is good news given the European backdrop. | our haven | |
21/5/2021 06:07 | chartwise AZN m now looks quite good for a further move upwards | arja | |
20/5/2021 17:13 | Montys shorts are well on fire now. | freddie ferret | |
20/5/2021 15:57 | I see Alexion is over $175 per adr - yet AZN remains below £86 per share. | stutes | |
12/5/2021 12:28 | In one way the CEO's pay is, in my opinion, a deliver or be sacked for under performing ultimatum; interestingly the ultimatum being set by the Board. | stutes | |
12/5/2021 09:56 | The Alexion deal received shareholders' approval. The drop in the share price, initially put down to the price and fears over integration, remains in part. I think it could take a few quarters before the City warms to the deal? | stutes | |
10/5/2021 16:36 | Firstly I accept executive pay should be fair. What I don't accept, if a company buys another then pay shouldn't go up to reflect a bigger business - if an executive works 12hrs for the firm buying the company, after the merger does it mean the executive has to work 15 hrs+ day , more than likely executive(s) are appointed to take the burden off the CEO. | stutes | |
10/5/2021 15:08 | If Alexion needs AZN to bankroll its pipeline then the balance of power is with AZN - AZN doesn't need to buy 100% of Alexion but a smaller % and access to the future pipeline. | stutes | |
09/5/2021 14:26 | Live Coronavirus latest news: Europe will not renew order for extra AstraZeneca vaccine doses Sarah Newey, global health security correspondent Ewan Somerville 9 MAY 2021 • 2:13PM The European Commission has not renewed its order for AstraZeneca vaccines beyond June, amid legal disputes and a pivot towards the Pfizer jab. According to the European Internal Market Commissioner, Thierry Breton, Europe will not order additional doses of the Oxford-AstraZeneca jab moving forward. The European Commission could have triggered a clause for additional 100 million doses of the vaccine. "We did not renew the order after June. We’ll see what happens," said Breton, adding that it was "a very good vaccine". Such a move is not unexpected amid fraught relations. Last month the Commission launched legal action against AstraZeneca for not respecting its contract for the supply of Covid-19 vaccines and for not having a "reliable" plan to ensure timely deliveries. And this week the bloc cemented its desire to use the Pfizer-BioNTech for the bulk of its rollout moving forward. Yesterday, the European Commission agreed to a massive contract extension for a potential 1.8 billion doses of the mRNA vaccine through 2023. Commission President, Ursula von der Leyen, said her office has approved a contract for a guaranteed 900 million doses with the same amount of doses as a future option. The new agreement, which has the unanimous backing of the 27 EU member nations, will entail not only the production of the vaccines but also making sure that all the essential components are sourced from the EU. Meanwhile the head of the Oxford University vaccine group urged wealthy countries, including the UK, to share available vaccines with the rest of the world before pursuing plans to offer citizens booster shots. "We're facing an absolute calamity," Prof Pollard told BBC, pointing to research which shows that around 30,000 people around the world will die from Covid-19 today alone. | maxk | |
08/5/2021 15:36 | FF, Lol! Have a good weekend. | beckers2008 | |
08/5/2021 01:01 | Interesting how the posting rate has dropped right off. Maybe it is just that nutters have appeared? (not you Beckers). | freddie ferret | |
07/5/2021 09:42 | AstraZeneca: 06/05/21 - Liberum reiterates buy with a target price of 9,220p | beckers2008 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions